Board of Directors
Read more:
Board of Directors
Gisela Sitbon
Born 1958
Board member since 2012, Chairperson since 2014
Chairperson of the board, chairperson of the remuneration committee
Education and training:
PhD in Medical Sciences from the Karolinska Institute in Solna
Main experience:
Gisela Sitbon has over 25 years of experience from the life science industry, of which more than ten years in senior positions (including CEO) at Professional Genetics Laboratory AB and five years as section manager at Karo Bio AB.
Other appointments:
Active as business coach within the life science sector. Chairman of the board of Gradientech AB and Emplicure AB. Board member of Sitbon Bioscience Partner Zenz AB.
Holdings:
Holds 26,666 shares through the company Sitbon Bioscience Partner Zenz AB.
Independent in relation to company and company management: Yes
Independent in relation to primary owners: Yes
Mattias Bengtsson
Born 1969
Board member since 2019
Member of the audit committee
EDUCATION AND TRAINING:
Master of Science in Chemical Engineering at Chalmers University of Technology in Gothenburg, MBA at University of Gothenburg School of Business
MAIN EXPERIENCE:
Mattias Bengtsson has more than 20 years of experience from the chemical and life science industry. He has held senior positions within AkzoNobel, more specifically in industrial purification of pharmaceuticals, for example as General Manager Kromasil and Fine Chemicals, Global Sales and Marketing Manager, Manufacturing Manager and Product Category Manager. In addition, Mattias has held several positions in process chemistry at AstraZeneca in Södertälje.
OTHER APPOINTMENTS:
Business Unit Manager BioMedical & Research, AddLife AB. Board member of MaBeRo Consulting AB, Bergman Labora AB, LabRobot AB, LabVent Control AS, Holm&Halby AS and EuroClone Spa.
Holdings:
Holds 13,000 shares.
Independent in relation to company and company management: No
Independent in relation to primary owners: Yes
Eva Byröd
Born 1952
Board member since 2017
EDUCATION AND TRAINING:
Master of Science in Chemical Engineering Chalmers University of Technology
MAIN EXPERIENCE:
Eva Byröd has more than 25 years of experience as line manager in pharmaceutical research and development and ten years of experience as project manager with work in drug development projects in both early and late phases.
OTHER APPOINTMENTS:
Board member of Eva Byröd Consulting AB and deputy board member of Bo Karlberg Arkitektur & Utveckling AB.
HOLDINGS: –
Independent in relation to company and company management: Yes
Independent in relation to primary owners: Yes
Thomas Eldered
Born 1960
Board member since 2021
Member of the audit committee
Education and training:
Master of Science in Industrial Economics, Linköpings tekniska högskola
Main experience:
Thomas Eldered is co-founder of Recipharm AB where he also worked as CEO between 2008–2021. Prior to that, Thomas was Vice President of Recip AB and Factory Manager for Pharmacia. Thomas has also held various assignments as chairman of the board, board member or deputy board member in companies primarily in the life science sector.
Other appointments:
Operative chairman of Flerie Invest AB, chairman of Amarna Therapeutics BV, Prokarium Ltd and North X Biologics AB. Board member of Chromafora AB, Bohus Biotech AB, Buzzard Pharmaceuticals AB, Sixera Pharma AB, Kahr Medical Ltd, Flerie Förvaltning AB, Cordinvest AB, Pingvinen Penningplacering AB, Xintela AB (publ), Toleranzia AB (publ), Flerie Participation AB.
Holdings:
Holds 14,901,635 shares through Flerie Invest AB.
Independent in relation to company and company management: Yes
Independent in relation to primary owners: No
Tomas Kramar
Born 1954
Board member since 2020
Member of the remuneration committee
Education and training:
Master of Science in Chemical Engineering from Lund University of Technology
Main experience:
Tomas Kramar has 40 years of experience from leading both large companies and start-ups. Most recently CEO of Siemens Healthineers and former CEO of Siemens Healthcare Diagnostics. Tomas has also been a board member and chairman of the board of large and small companies.
Other appointments:
Chairman of the board of Cardeon AB (publ), T.M. Kramar Group AB and Percy Falk cancerstiftelse. Board member of SpectraCure AB (publ), Corsmed AB, CytaCoat AB, Deep Light Vision AB and Lundonia Biotech AB.
Holdings:
Holds 30,000 shares.
Independent in relation to company and company management: Yes
Independent in relation to primary owners: Yes
Anders Rabbe
Born 1970
Board member since 2020
Member of the remuneration committee
Education and training:
Bachelor of Economics in Business Administration from Webster University, Genève.
Main experience:
Anders Rabbe has been the CEO of several companies in the biotechnology and financial sector, including Isofol Medical (publ) and WntResearch AB (publ).
Other appointments:
CEO of Mindforce Game Lab AB. Board member and partner in Akkumula AB, Albonja AB and Epicyt Pharma AB.
Holdings:
Holds 13,333 shares.
Independent in relation to company and company management: Yes
Independent in relation to primary owners: Yes
Lena Torlegård
Born 1963
Board member since 2014
Member of the audit committee
EDUCATION AND TRAINING:
Bachelor of Science in Business Administration from the Stockholm School of Economics
MAIN EXPERIENCE:
Lena Torlegård has over 20 years of experience as a communications consultant for a large number of companies, including companies in the life science industry. Lena works through Lena Torlegård AB as an independent advisor in financial and corporate communication with several customers in the life science sector.
OTHER APPOINTMENTS:
Communications consultant at Lena Torlegård AB. Chairman of the board of CoDesignSweden AB.
Holdings:
Holds 7,652 shares.
Independent in relation to company and company management: Yes
Independent in relation to primary owners: Yes